143 related articles for article (PubMed ID: 22721571)
1. Positive health beliefs and behaviours in the midst of difficult lives: women who inject drugs.
Olsen A; Banwell C; Dance P; Maher L
Int J Drug Policy; 2012 Jul; 23(4):312-8. PubMed ID: 22721571
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
Iversen J; Wand H; Gonnermann A; Maher L;
Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
[TBL] [Abstract][Full Text] [Related]
3. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia.
Crockett B; Gifford SM
Women Health; 2004; 39(4):117-37. PubMed ID: 15691088
[TBL] [Abstract][Full Text] [Related]
4. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
Treloar C; Newland J; Rance J; Hopwood M
J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
[TBL] [Abstract][Full Text] [Related]
5. Staying safe from hepatitis C: engaging with multiple priorities.
Harris M; Treloar C; Maher L
Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
[TBL] [Abstract][Full Text] [Related]
6. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
[TBL] [Abstract][Full Text] [Related]
7. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
[TBL] [Abstract][Full Text] [Related]
8. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
Harris M; Rhodes T
Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
[TBL] [Abstract][Full Text] [Related]
9. Beyond risk factors to lived experiences: young women's experiences of health in Papua New Guinea.
Hinton RL; Earnest J
Rural Remote Health; 2009; 9(4):1257. PubMed ID: 19895179
[TBL] [Abstract][Full Text] [Related]
10. Reinforced biographies among women living with hepatitis C.
Olsen A; Banwell C; Dance P
Qual Health Res; 2013 Apr; 23(4):531-40. PubMed ID: 23258115
[TBL] [Abstract][Full Text] [Related]
11. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
Park JN; White B; Bates A; Enriquez J; Liao L; Maher L
Drug Alcohol Depend; 2012 Jun; 123(1-3):35-40. PubMed ID: 22071117
[TBL] [Abstract][Full Text] [Related]
12. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
Rance J; Newland J; Hopwood M; Treloar C
Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.
Treloar C; Hull P; Bryant J; Hopwood M; Grebely J; Lavis Y
Drug Alcohol Depend; 2011 Jul; 116(1-3):52-6. PubMed ID: 21194852
[TBL] [Abstract][Full Text] [Related]
14. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
Hopwood M; Treloar C
Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
[TBL] [Abstract][Full Text] [Related]
15. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.
Jones L; Atkinson A; Bates G; McCoy E; Porcellato L; Beynon C; McVeigh J; Bellis MA
Int J Drug Policy; 2014 Mar; 25(2):204-11. PubMed ID: 24332457
[TBL] [Abstract][Full Text] [Related]
16. Use of respondent-driven sampling to enhance understanding of injecting networks: a study of people who inject drugs in Sydney, Australia.
Paquette DM; Bryant J; De Wit J
Int J Drug Policy; 2011 Jul; 22(4):267-73. PubMed ID: 21550790
[TBL] [Abstract][Full Text] [Related]
17. Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.
Bruneau J; Zang G; Abrahamowicz M; Jutras-Aswad D; Daniel M; Roy E
Clin Infect Dis; 2014 Mar; 58(6):755-61. PubMed ID: 24363333
[TBL] [Abstract][Full Text] [Related]
18. Seeking refuge from violence in street-based drug scenes: women's experiences in North America's first supervised injection facility.
Fairbairn N; Small W; Shannon K; Wood E; Kerr T
Soc Sci Med; 2008 Sep; 67(5):817-23. PubMed ID: 18562065
[TBL] [Abstract][Full Text] [Related]
19. On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
Chikovani I; Ompad DC; Uchaneishvili M; Sulaberidze L; Sikharulidze K; Hagan H; Van Devanter NL
PLoS One; 2019; 14(4):e0216123. PubMed ID: 31034530
[TBL] [Abstract][Full Text] [Related]
20. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
